Molecular basis of severe malaria.

نویسندگان

  • Kirk W Deitsch
  • Chetan E Chitnis
چکیده

M alaria is an ancient scourge that continues to plague many regions of the developing world. Despite its long history, many aspects of the disease remain difficult to explain. For example, why some individuals experience relatively mild symptoms and others progress to severe and sometimes lethal disease is not understood. Similarly, the molecular basis for immunity to severe malaria is poorly defined. Three studies in PNAS (1–3) cast significant light on this subject. Malaria parasites reside within circulating erythrocytes, where they modify the host cell cytoskeleton and membrane, placing a protein called Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) on the cell surface (4). This protein binds to receptors on the surface of vascular endothelial cells, thereby sequestering the infected cells within various tissues. This property can have severe consequences for the human host, causing inflammation, circulatory obstruction, and organ-specific damage (4). Infected individuals readily make antibodies that efficiently recognize PfEMP1, disrupting adhesion and leading to destruction of the infected erythrocytes. To avoid this fate, parasites have evolved a multicopy gene family called var. Each var gene encodes a variant form of PfEMP1 (5–7). By switching expression between different var genes, parasites can avoid the host’s antibody response and establish chronic infection. Significant work has demonstrated that different forms of PfEMP1 display different adhesive properties (8), leading to a simple paradigm: The organs in which infected cells sequester and, consequently, the severity of the disease are determined by which var genes are expressed (Fig. 1). Further, if specific PfEMP1 types are associated with severe disease, it might be possible to develop intervention strategies that specifically target these PfEMP1 types. This paradigm was validated with the discovery of a specific var gene that confers adhesion of infected cells within the placenta of pregnant women (9, 10). With the identification of a placenta-specific endothelial receptor (chondroitin sulfate A) (11) that is bound by a single PfEMP1 type (called VAR2CSA) (9, 10), the molecular interaction responsible for placental sequestration was illuminated. Subsequent studies showed that women who have suffered from placental malaria develop antibodies against VAR2CSA and appear to be immune to similar infections during subsequent pregnancies (12, 13), thus providing a strong rationale for development of a VAR2CSAbased vaccine. The success in identifying the basis for pregnancy-associated malaria led researchers to search for similar PfEMP1/ host receptor interactions underlying other severe malaria syndromes, particularly cerebral malaria. Different parasite isolates often carry almost completely different var gene repertoires; thus, within any geographical region, the variability within the var gene family is extensive (14). A notable exception is VAR2CSA, which is largely conserved. The extreme diversity of PfEMP1 forms makes identification of specific types associated with severe disease or cerebral malaria difficult. However, computational analysis of var gene sequences did enable the gene family to be divided into three basic types referred to as A, B, and C groups (15, 16). Subsequent field studies identified expression of group A var genes as being more frequently associated with severe disease (17, 18). The three reports in PNAS (1–3) identify a specific class of PfEMP1 that is associated with the incidence of cerebral malaria and severe disease. The studies by Avril et al. (1) and Claessens et al. (2) identify narrow subsets of group A var genes that were expressed by parasites selected to adhere with high affinity to endothelial cells derived from human brain tissue. When the encoded PfEMP1s were classified according to their domain architecture, they were found to possess one of two specific combinations of binding domain cassettes, referred to as DC8 or DC13, at their N-terminal ends (19). Interestingly, parasites expressing these var genes also bound to endothelial cells derived from nonbrain tissues; however, they did not bind intracellular adhesion molecule 1 (ICAM1), a host surface molecule previously proposed to be the endothelial receptor bound by infected erythrocytes in the brain. Both studies also found that serum from African children who had experienced severe malaria could recognize the selected parasite lines and disrupt binding to brain endothelial cells. PfEMP1 expressed by field isolates that cause severe malaria thus shares B-cell epitopes with laboratory strains selected for binding to brain endothelium. Limited diversity in B-cell epitopes in PfEMP1 expressed by parasite strains that cause severe disease suggests that it may be possible to elicit antibody responses that protect against severe malaria. These observations provide a rationale for the development of vaccines to protect against severe malaria. Using a different approach, the study by Lavstsen et al. (3) provides complementary data. Working with field samples, the authors compared var gene transcripts expressed by parasites isolated from patients suffering from either severe or uncomplicated malaria. Similar to the studies of Avril et al. (1) and Claessens et al. (2), they identify group A var genes with the DC8 or DC13 architecture as being associated with severe disease. Interestingly, they found that both cerebral malaria and severe anemia were associated with expression of DC8 or DC13 encoding var genes. Together, these three studies suggest that conserved domains constituting Adhesion in the Brain

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Impacts of Malaria on Severe Anemia in Children Aged 6-23 Months Old from the Rural District of Kongoussi, Burkina Faso

Background: The present cross-sectional study was conducted to measure the population attributable risk (PAR) of severe anemia among children aged 6-23 months in the rural district of Kongoussi, in Burkina Faso. Methods: Socio-demographic, clinical, anthropometric, and biological data were collected from children and mothers. Results: In total, 671 children were included in the analysis, 50.4% ...

متن کامل

Correlates of severity of disease in Macaca mulatta infected with Plasmodium cynomolgi

Characterization of host responses associated with severe malaria through an integrative approach is necessary to understand the dynamics of a Plasmodium cynomolgi infection. In this study, we conducted temporal immune profiling, cytokine profiling and transcriptomic analysis of five Macaca mulatta infected with P. cynomolgi. This experiment resulted in two severe infections, and two mild infec...

متن کامل

Clinical Pharmacology of the Antimalarial Quinine in Children

Quinine is the best studied drug for treating severe malaria in very young children. Quinine may be administered in pregnancy and, at therapeutic doses, malformations have not been reported. Some strains of quinine from Southeast Asia and South America have become resistant. Quinine is the treatment of choice for the drug-resistant severe Plasmodium falciparum. The antimalarial mechanism of qui...

متن کامل

The Impact of IL-18 and IFN-γ on Severity of Malaria and Quality of Treatment

Background & Objective: In human malaria, genotype of cytokines affect immune system. The impact of genotype -137G/C in IL-18 and +874A/T in IFN-γ on the severity of malaria and the quality of treatment – as factors to form asymptomatic persons in endemic regions- has been investigated.Materials & Methods: 100 patients and 102 healthy persons were evaluated by Nested-PCR and thick blood fil...

متن کامل

Molecular and Clinical Characterization of 7 Iranian Patients with Severe Congenital Factor V Deficiency: Identification of 4 Novel Mutations

Background and Aims: Congenital factor V (FV) deficiency is a rare bleeding disorder with 1 in 1000000 persons in the general population. Individuals with FV activity <1% and very low FV antigen levels are characterized as severe FV deficient patients. Little data is available about the molecular basis of this bleeding disorder in Iran. Materials and Methods: We analyzed 7 unrelated Iranian FV...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Proceedings of the National Academy of Sciences of the United States of America

دوره 109 26  شماره 

صفحات  -

تاریخ انتشار 2012